Skip to main content
PMC home page
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 2001;99:301–317.

Glaucoma patients' assessment of their visual function and quality of life.

H D Jampel 1
PMCID: PMC1359019  PMID: 11797316

Abstract

PURPOSE: To determine how glaucoma patients with various degrees of vision loss rate their vision, and to determine if the Esterman binocular visual field test and other visual function tests correlate with those ratings. METHODS: Two hundred thirty-seven glaucoma patients evaluated their vision using 2 utility tests, the linear rating scale and the time trade-off test, and 2 quality-of-life instruments, the National Eye Institute Visual Function Questionnaire (VFQ) and the Short Form 36 (SF-36). Their results were compared to clinical tests of their vision and to persons with normal vision (n = 12) and blind persons (n = 12). RESULTS: On a scale of 0 (blind) to 100 (ideal), subjects with normal vision rated their vision higher (90 +/- 8.0) than did glaucoma subjects and suspects (75.7 +/- 17.6) and "blind" subjects (15.6 +/- 15.3), P = .001. Mean scores for the Esterman test were 89.7 +/- 13.4 for the glaucoma group. The Esterman test correlated moderately with the overall VFQ score (partial correlation coefficient [PCC] = 0.32, P = .001), but only weakly with the linear rating scale (PCC = 0.17, P = .02) and the time trade-off test (PCC = -0.16, P = .06). Correlation between the linear rating scale and the overall VFQ score was good (PCC = 0.56, P = .0001) and was moderate with several domains of the SF-36 (e.g., social function PCC = 0.32, P = .0001). CONCLUSIONS: Utility values that glaucoma patients assign to their vision do not correlate well with Esterman test results. A challenge for the future will be designing clinical tests that better correlate with patient perceptions.

Full Text

The Full Text of this article is available as a PDF (297.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barber B. L., Strahlman E. R., Laibovitz R., Guess H. A., Reines S. A. Validation of a questionnaire for comparing the tolerability of ophthalmic medications. Ophthalmology. 1997 Feb;104(2):334–342. doi: 10.1016/s0161-6420(97)30314-5. [DOI] [PubMed] [Google Scholar]
  2. Bass E. B., Wills S., Scott I. U., Javitt J. C., Tielsch J. M., Schein O. D., Steinberg E. P. Preference values for visual states in patients planning to undergo cataract surgery. Med Decis Making. 1997 Jul-Sep;17(3):324–330. doi: 10.1177/0272989X9701700309. [DOI] [PubMed] [Google Scholar]
  3. Brown G. C., Brown M. M., Sharma S. Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration. Can J Ophthalmol. 2000 Apr;35(3):127–133. doi: 10.1016/s0008-4182(00)80005-8. [DOI] [PubMed] [Google Scholar]
  4. Brown G. C., Sharma S., Brown M. M., Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol. 2000 Jan;118(1):47–51. doi: 10.1001/archopht.118.1.47. [DOI] [PubMed] [Google Scholar]
  5. Brown G. C. Vision and quality-of-life. Trans Am Ophthalmol Soc. 1999;97:473–511. [PMC free article] [PubMed] [Google Scholar]
  6. Brown M. M., Brown G. C., Sharma S., Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol. 1999 Sep;128(3):324–330. doi: 10.1016/s0002-9394(99)00146-4. [DOI] [PubMed] [Google Scholar]
  7. Buckingham J. K., Birdsall J., Douglas J. G. Comparing three versions of the time tradeoff: time for a change? Med Decis Making. 1996 Oct-Dec;16(4):335–347. doi: 10.1177/0272989X9601600404. [DOI] [PubMed] [Google Scholar]
  8. Cassard S. D., Patrick D. L., Damiano A. M., Legro M. W., Tielsch J. M., Diener-West M., Schein O. D., Javitt J. C., Bass E. B., Steinberg E. P. Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Arch Ophthalmol. 1995 Dec;113(12):1508–1513. doi: 10.1001/archopht.1995.01100120038005. [DOI] [PubMed] [Google Scholar]
  9. Cole S. R., Beck R. W., Moke P. S., Gal R. L., Long D. T. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1017–1021. [PubMed] [Google Scholar]
  10. Courtright P., Poon C. I., Richards J. S., Chow D. L., Holland S. P. Visual function among corneal disease patients waiting for penetrating keratoplasty in British Columbia. Ophthalmic Epidemiol. 1998 Mar;5(1):13–20. doi: 10.1076/opep.5.1.13.1498. [DOI] [PubMed] [Google Scholar]
  11. Crabb D. P., Viswanathan A. C., McNaught A. I., Poinoosawmy D., Fitzke F. W., Hitchings R. A. Simulating binocular visual field status in glaucoma. Br J Ophthalmol. 1998 Nov;82(11):1236–1241. doi: 10.1136/bjo.82.11.1236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cruickshanks K. J., Fryback D. G., Nondahl D. M., Robinson N., Keesey U., Dalton D. S., Robertson D. M., Chandra S. R., Mieler W. F., Zakov Z. N. Treatment choice and quality of life in patients with choroidal melanoma. Arch Ophthalmol. 1999 Apr;117(4):461–467. doi: 10.1001/archopht.117.4.461. [DOI] [PubMed] [Google Scholar]
  13. Esterman B. Functional scoring of the binocular field. Ophthalmology. 1982 Nov;89(11):1226–1234. doi: 10.1016/s0161-6420(82)34647-3. [DOI] [PubMed] [Google Scholar]
  14. Feeny D. H., Torrance G. W. Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples. Med Care. 1989 Mar;27(3 Suppl):S190–S204. doi: 10.1097/00005650-198903001-00016. [DOI] [PubMed] [Google Scholar]
  15. Freitas C., Oliveiros B. M., Marques E., Leite E. B. Effect of photorefractive keratectomy on visual functioning and quality of life. J Refract Surg. 1995 May-Jun;11(3 Suppl):S327–S334. doi: 10.3928/1081-597X-19950502-29. [DOI] [PubMed] [Google Scholar]
  16. Froberg D. G., Kane R. L. Methodology for measuring health-state preferences--II: Scaling methods. J Clin Epidemiol. 1989;42(5):459–471. doi: 10.1016/0895-4356(89)90136-4. [DOI] [PubMed] [Google Scholar]
  17. Froberg D. G., Kane R. L. Methodology for measuring health-state preferences--IV: Progress and a research agenda. J Clin Epidemiol. 1989;42(7):675–685. doi: 10.1016/0895-4356(89)90011-5. [DOI] [PubMed] [Google Scholar]
  18. Gordon M. O., Kass M. A. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol. 1999 May;117(5):573–583. doi: 10.1001/archopht.117.5.573. [DOI] [PubMed] [Google Scholar]
  19. Green C., Brazier J., Deverill M. Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics. 2000 Feb;17(2):151–165. doi: 10.2165/00019053-200017020-00004. [DOI] [PubMed] [Google Scholar]
  20. Gutierrez P., Wilson M. R., Johnson C., Gordon M., Cioffi G. A., Ritch R., Sherwood M., Meng K., Mangione C. M. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997 Jun;115(6):777–784. doi: 10.1001/archopht.1997.01100150779014. [DOI] [PubMed] [Google Scholar]
  21. Javitt J. C., Steinberg E. P., Sharkey P., Schein O. D., Tielsch J. M., Diener M., Legro M., Sommer A. Cataract surgery in one eye or both. A billion dollar per year issue. Ophthalmology. 1995 Nov;102(11):1583–1593. doi: 10.1016/s0161-6420(95)30824-x. [DOI] [PubMed] [Google Scholar]
  22. Javitt J. C., Wang F., Trentacost D. J., Rowe M., Tarantino N. Outcomes of cataract extraction with multifocal intraocular lens implantation: functional status and quality of life. Ophthalmology. 1997 Apr;104(4):589–599. doi: 10.1016/s0161-6420(97)30265-6. [DOI] [PubMed] [Google Scholar]
  23. Kassirer J. P. Incorporating patients' preferences into medical decisions. N Engl J Med. 1994 Jun 30;330(26):1895–1896. doi: 10.1056/NEJM199406303302611. [DOI] [PubMed] [Google Scholar]
  24. Klein B. E., Klein R., Jensen S. C. A short questionnaire on visual function of older adults to supplement ophthalmic examination. Am J Ophthalmol. 2000 Sep;130(3):350–352. doi: 10.1016/s0002-9394(00)00544-4. [DOI] [PubMed] [Google Scholar]
  25. Lee B. L., Gutierrez P., Gordon M., Wilson M. R., Cioffi G. A., Ritch R., Sherwood M., Mangione C. M. The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms. Arch Ophthalmol. 1998 Jul;116(7):861–866. doi: 10.1001/archopht.116.7.861. [DOI] [PubMed] [Google Scholar]
  26. Lee B. L., Wilson M. R. Health-related quality of life in patients with cataract and glaucoma. J Glaucoma. 2000 Feb;9(1):87–94. doi: 10.1097/00061198-200002000-00015. [DOI] [PubMed] [Google Scholar]
  27. Linder M., Chang T. S., Scott I. U., Hay D., Chambers K., Sibley L. M., Weis E. Validity of the visual function index (VF-14) in patients with retinal disease. Arch Ophthalmol. 1999 Dec;117(12):1611–1616. doi: 10.1001/archopht.117.12.1611. [DOI] [PubMed] [Google Scholar]
  28. Mangione C. M., Berry S., Spritzer K., Janz N. K., Klein R., Owsley C., Lee P. P. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998 Feb;116(2):227–233. doi: 10.1001/archopht.116.2.227. [DOI] [PubMed] [Google Scholar]
  29. Mangione C. M., Gutierrez P. R., Lowe G., Orav E. J., Seddon J. M. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol. 1999 Jul;128(1):45–53. doi: 10.1016/s0002-9394(99)00169-5. [DOI] [PubMed] [Google Scholar]
  30. Mangione C. M., Lee P. P., Pitts J., Gutierrez P., Berry S., Hays R. D. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998 Nov;116(11):1496–1504. doi: 10.1001/archopht.116.11.1496. [DOI] [PubMed] [Google Scholar]
  31. Mangione C. M., Phillips R. S., Lawrence M. G., Seddon J. M., Orav E. J., Goldman L. Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol. 1994 Nov;112(11):1419–1425. doi: 10.1001/archopht.1994.01090230033017. [DOI] [PubMed] [Google Scholar]
  32. Mangione C. M., Phillips R. S., Lawrence M. G., Seddon J. M., Orav E. J., Goldman L. Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol. 1994 Nov;112(11):1419–1425. doi: 10.1001/archopht.1994.01090230033017. [DOI] [PubMed] [Google Scholar]
  33. Mangione C. M., Phillips R. S., Seddon J. M., Lawrence M. G., Cook E. F., Dailey R., Goldman L. Development of the 'Activities of Daily Vision Scale'. A measure of visual functional status. Med Care. 1992 Dec;30(12):1111–1126. doi: 10.1097/00005650-199212000-00004. [DOI] [PubMed] [Google Scholar]
  34. McHorney C. A., Ware J. E., Jr, Lu J. F., Sherbourne C. D. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994 Jan;32(1):40–66. doi: 10.1097/00005650-199401000-00004. [DOI] [PubMed] [Google Scholar]
  35. Melia B. M., Moy C. S., McCaffrey L. Quality of life in patients with choroidal melanoma: a pilot study. Ophthalmic Epidemiol. 1999 Mar;6(1):19–28. doi: 10.1076/opep.6.1.19.1570. [DOI] [PubMed] [Google Scholar]
  36. Mills R. P. Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis. Trans Am Ophthalmol Soc. 1998;96:753–812. [PMC free article] [PubMed] [Google Scholar]
  37. Mills R. P., Drance S. M. Esterman disability rating in severe glaucoma. Ophthalmology. 1986 Mar;93(3):371–378. doi: 10.1016/s0161-6420(86)33732-1. [DOI] [PubMed] [Google Scholar]
  38. Parrish R. K., 2nd, Gedde S. J., Scott I. U., Feuer W. J., Schiffman J. C., Mangione C. M., Montenegro-Piniella A. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997 Nov;115(11):1447–1455. doi: 10.1001/archopht.1997.01100160617016. [DOI] [PubMed] [Google Scholar]
  39. Parrish R. K., 2nd Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. Trans Am Ophthalmol Soc. 1996;94:919–1028. [PMC free article] [PubMed] [Google Scholar]
  40. Rose K., Harper R., Tromans C., Waterman C., Goldberg D., Haggerty C., Tullo A. Quality of life in myopia. Br J Ophthalmol. 2000 Sep;84(9):1031–1034. doi: 10.1136/bjo.84.9.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Scott I. U., Schein O. D., West S., Bandeen-Roche K., Enger C., Folstein M. F. Functional status and quality of life measurement among ophthalmic patients. Arch Ophthalmol. 1994 Mar;112(3):329–335. doi: 10.1001/archopht.1994.01090150059023. [DOI] [PubMed] [Google Scholar]
  42. Sharma S., Brown G. C., Brown M. M., Hollands H., Shah G. K. The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis. Curr Opin Ophthalmol. 2000 Jun;11(3):175–179. doi: 10.1097/00055735-200006000-00004. [DOI] [PubMed] [Google Scholar]
  43. Sherwood M. B., Garcia-Siekavizza A., Meltzer M. I., Hebert A., Burns A. F., McGorray S. Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study. Ophthalmology. 1998 Mar;105(3):561–566. doi: 10.1016/S0161-6420(98)93043-3. [DOI] [PubMed] [Google Scholar]
  44. Steinberg E. P., Tielsch J. M., Schein O. D., Javitt J. C., Sharkey P., Cassard S. D., Legro M. W., Diener-West M., Bass E. B., Damiano A. M. National study of cataract surgery outcomes. Variation in 4-month postoperative outcomes as reflected in multiple outcome measures. Ophthalmology. 1994 Jun;101(6):1131–1141. doi: 10.1016/s0161-6420(94)31210-3. [DOI] [PubMed] [Google Scholar]
  45. Steinberg E. P., Tielsch J. M., Schein O. D., Javitt J. C., Sharkey P., Cassard S. D., Legro M. W., Diener-West M., Bass E. B., Damiano A. M. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol. 1994 May;112(5):630–638. doi: 10.1001/archopht.1994.01090170074026. [DOI] [PubMed] [Google Scholar]
  46. Tarlov A. R., Ware J. E., Jr, Greenfield S., Nelson E. C., Perrin E., Zubkoff M. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA. 1989 Aug 18;262(7):925–930. doi: 10.1001/jama.262.7.925. [DOI] [PubMed] [Google Scholar]
  47. Torrance G. W., Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;5(4):559–575. doi: 10.1017/s0266462300008461. [DOI] [PubMed] [Google Scholar]
  48. Torrance G. W., Thomas W. H., Sackett D. L. A utility maximization model for evaluation of health care programs. Health Serv Res. 1972 Summer;7(2):118–133. [PMC free article] [PubMed] [Google Scholar]
  49. Torrance G. W. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40(6):593–603. doi: 10.1016/0021-9681(87)90019-1. [DOI] [PubMed] [Google Scholar]
  50. Turano K. A., Rubin G. S., Quigley H. A. Mobility performance in glaucoma. Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2803–2809. [PubMed] [Google Scholar]
  51. Vitale S., Schein O. D., Meinert C. L., Steinberg E. P. The refractive status and vision profile: a questionnaire to measure vision-related quality of life in persons with refractive error. Ophthalmology. 2000 Aug;107(8):1529–1539. doi: 10.1016/s0161-6420(00)00171-8. [DOI] [PubMed] [Google Scholar]
  52. Ware J. E., Jr, Sherbourne C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–483. [PubMed] [Google Scholar]
  53. Wilson M. R., Coleman A. L., Yu F., Bing E. G., Sasaki I. F., Berlin K., Winters J., Lai A. Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology. 1998 Nov;105(11):2112–2116. doi: 10.1016/S0161-6420(98)91135-6. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES